EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 152 filers reported holding EDITAS MEDICINE INC in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157 | +5.4% | 20,141 | -2.0% | 0.01% | -13.3% |
| Q1 2023 | $149 | -10.2% | 20,549 | +9.6% | 0.02% | -28.6% |
| Q4 2022 | $166 | -99.9% | 18,746 | -8.6% | 0.02% | -36.4% |
| Q3 2022 | $251,000 | -69.2% | 20,506 | -70.3% | 0.03% | -73.0% |
| Q2 2022 | $816,000 | +253.2% | 69,000 | +469.1% | 0.12% | +293.5% |
| Q1 2022 | $231,000 | -22.2% | 12,124 | +8.2% | 0.03% | -16.2% |
| Q4 2021 | $297,000 | +5.3% | 11,201 | +63.2% | 0.04% | +27.6% |
| Q3 2021 | $282,000 | -27.9% | 6,864 | -56.6% | 0.03% | -34.1% |
| Q2 2019 | $391,000 | -50.2% | 15,817 | -50.7% | 0.04% | -45.0% |
| Q1 2019 | $785,000 | -9.9% | 32,100 | +22.1% | 0.08% | +73.9% |
| Q1 2018 | $871,000 | +30.6% | 26,285 | -5.4% | 0.05% | +2.2% |
| Q3 2017 | $667,000 | – | 27,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |